We are live on
!
Find out more
GLRA
Gerald L. Ray & Associates Portfolio holdings
AUM
$802M
1-Year Est. Return
21.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.97%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$626M
AUM Growth
+$8.63M
(+1.4%)
Cap. Flow
+$2.02M
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
316
New
18
Increased
76
Reduced
109
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour Class C
UA
|
+$4.22M |
| 2 |
SBA Communications
SBAC
|
+$780K |
| 3 |
APA Corp
APA
|
+$729K |
| 4 |
Agios Pharmaceuticals
AGIO
|
+$711K |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$529K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$4.6M |
| 2 |
SNDK
SANDISK CORP
SNDK
|
+$1.38M |
| 3 |
HUSI.PRG
HSBC USA INC DEP SHS REPSTG 1/40 PRD SER G
HUSI.PRG
|
+$794K |
| 4 |
Goldman Sachs
GS
|
+$590K |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$414K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.93% |
| 2 | Industrials | 14.1% |
| 3 | Consumer Staples | 12.44% |
| 4 | Technology | 8.21% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
301
DELISTED
Esperion Therapeutics
ESPR
| – | – |
-13,800
| Closed | -$233K |
|
302
Liberty Media Series C
FWONK
$25.4B
| – | – |
-9,093
| Closed | -$245K |
|
303
Liberty Global Class C
LBTYK
$3.4B
| – | – |
-7,202
| Closed | -$235K |
|
304
LyondellBasell Industries
LYB
$18.8B
| – | – |
-2,450
| Closed | -$210K |
|
|
CLVS
305
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-21,560
| Closed | -$414K |
|
|
WBC
306
DELISTED
WABCO HOLDINGS INC.
WBC
| – | – |
-2,000
| Closed | -$214K |
|
|
BXLT
307
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| – | – |
-10,100
| Closed | -$408K |
|
|
HUSI.PRG
308
DELISTED
HSBC USA INC DEP SHS REPSTG 1/40 PRD SER G
HUSI.PRG
| – | – |
-33,650
| Closed | -$794K |
|
|
SNDK
309
DELISTED
SANDISK CORP
SNDK
| – | – |
-18,180
| Closed | -$1.38M |
|
|
MHFI
310
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| – | – |
-2,600
| Closed | -$257K |
|
|
LNKD
311
DELISTED
LinkedIn Corporation
LNKD
| – | – |
-2,770
| Closed | -$317K |
|
|
TWC
312
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| – | – |
-1,534
| Closed | -$314K |
|
Similar funds
KRC
GS
PAAMCP
B
JPCCM
NBC
NTC
SD
Gerald L. Ray & Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Gerald L. Ray & Associates held 316 positions worth $626M, up 1.4% from $617M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Gerald L. Ray & Associates's Q2 2016 filing shows 18 new, 76 increased, 109 reduced and 13 closed positions. Its largest new stake was Under Armour Class C: 114,470 shares worth $4.17M. The largest sale was Under Armour, an estimated $4.6M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Staples.
- Gerald L. Ray & Associates's largest Q2 2016 buy was Under Armour Class C: 114,470 shares worth $4.17M.
- Gerald L. Ray & Associates added most to APA Corp in Q2 2016, an estimated $729K increase.
- Gerald L. Ray & Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $4.6M.
- Gerald L. Ray & Associates fully exited SANDISK CORP in Q2 2016, selling an estimated $1.38M.
- Gerald L. Ray & Associates's ten largest holdings make up 28% of its $626M portfolio in Q2 2016.
- Gerald L. Ray & Associates opened 18 new positions and closed 13 in Q2 2016.
- Gerald L. Ray & Associates's portfolio value rose 1.4% quarter-over-quarter to $626M.
Based on Gerald L. Ray & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.